Suppr超能文献

相似文献

1
Convergent Identification and Interrogation of Tumor-Intrinsic Factors that Modulate Cancer Immunity In Vivo.
Cell Syst. 2019 Feb 27;8(2):136-151.e7. doi: 10.1016/j.cels.2019.01.004. Epub 2019 Feb 20.
2
A CRISPR Platform for Targeted In Vivo Screens.
Methods Mol Biol. 2023;2614:397-409. doi: 10.1007/978-1-0716-2914-7_24.
3
Cancer CRISPR Screens In Vivo.
Trends Cancer. 2018 May;4(5):349-358. doi: 10.1016/j.trecan.2018.03.002. Epub 2018 Mar 30.
4
Mapping a functional cancer genome atlas of tumor suppressors in mouse liver using AAV-CRISPR-mediated direct in vivo screening.
Sci Adv. 2018 Feb 28;4(2):eaao5508. doi: 10.1126/sciadv.aao5508. eCollection 2018 Feb.
5
Spatial CRISPR genomics identifies regulators of the tumor microenvironment.
Cell. 2022 Mar 31;185(7):1223-1239.e20. doi: 10.1016/j.cell.2022.02.015. Epub 2022 Mar 14.
6
CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes.
Nat Biotechnol. 2016 Jun;34(6):631-3. doi: 10.1038/nbt.3536. Epub 2016 Apr 25.
7
CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
Cancer Lett. 2019 Apr 10;447:48-55. doi: 10.1016/j.canlet.2019.01.017. Epub 2019 Jan 23.
8
High-content CRISPR screening in tumor immunology.
Front Immunol. 2022 Nov 21;13:1041451. doi: 10.3389/fimmu.2022.1041451. eCollection 2022.
9
Functional CRISPR screens in T cells reveal new opportunities for cancer immunotherapies.
Mol Cancer. 2024 Apr 5;23(1):73. doi: 10.1186/s12943-024-01987-z.
10
Engineered CRISPR Systems for Next Generation Gene Therapies.
ACS Synth Biol. 2017 Sep 15;6(9):1614-1626. doi: 10.1021/acssynbio.7b00011. Epub 2017 Jun 7.

引用本文的文献

1
Crosstalk between KIF1C and PRKAR1A in left atrial myxoma.
Commun Biol. 2023 Jul 14;6(1):724. doi: 10.1038/s42003-023-05094-5.
2
Applications of CRISPR technology in cellular immunotherapy.
Immunol Rev. 2023 Nov;320(1):199-216. doi: 10.1111/imr.13241. Epub 2023 Jul 14.
3
Opportunities and Challenges of Kava in Lung Cancer Prevention.
Int J Mol Sci. 2023 May 31;24(11):9539. doi: 10.3390/ijms24119539.
4
Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function.
Cancer Immunol Res. 2023 Aug 3;11(8):1068-1084. doi: 10.1158/2326-6066.CIR-22-0565.
5
Immunogenetic metabolomics revealed key enzymes that modulate CAR-T metabolism and function.
bioRxiv. 2023 Mar 15:2023.03.14.532663. doi: 10.1101/2023.03.14.532663.
8
Tumor immunology CRISPR screening: present, past, and future.
Trends Cancer. 2022 Mar;8(3):210-225. doi: 10.1016/j.trecan.2021.11.009. Epub 2021 Dec 15.
9
In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target.
Cell. 2021 Oct 14;184(21):5357-5374.e22. doi: 10.1016/j.cell.2021.09.006. Epub 2021 Sep 27.
10
Progress and Clinical Application of Single-Cell Transcriptional Sequencing Technology in Cancer Research.
Front Oncol. 2021 Feb 3;10:593085. doi: 10.3389/fonc.2020.593085. eCollection 2020.

本文引用的文献

1
Integrating single-cell transcriptomic data across different conditions, technologies, and species.
Nat Biotechnol. 2018 Jun;36(5):411-420. doi: 10.1038/nbt.4096. Epub 2018 Apr 2.
2
A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.
Science. 2018 Feb 16;359(6377):770-775. doi: 10.1126/science.aao1710. Epub 2018 Jan 4.
3
Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion.
Hepatology. 2018 Oct;68(4):1441-1447. doi: 10.1002/hep.29719. Epub 2018 May 11.
4
fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma.
Proc Natl Acad Sci U S A. 2017 Dec 12;114(50):13076-13084. doi: 10.1073/pnas.1716483114. Epub 2017 Nov 21.
6
Correction of aberrant growth preserves tissue homeostasis.
Nature. 2017 Aug 17;548(7667):334-337. doi: 10.1038/nature23304. Epub 2017 Aug 2.
7
Identification of essential genes for cancer immunotherapy.
Nature. 2017 Aug 31;548(7669):537-542. doi: 10.1038/nature23477. Epub 2017 Aug 7.
8
Novel PRKAR1A mutation in Carney complex with cardiac myxoma.
Pediatr Int. 2017 Jul;59(7):840-841. doi: 10.1111/ped.13302.
9
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.
Nature. 2017 Jul 27;547(7664):413-418. doi: 10.1038/nature23270. Epub 2017 Jul 19.
10
Differential analysis of RNA-seq incorporating quantification uncertainty.
Nat Methods. 2017 Jul;14(7):687-690. doi: 10.1038/nmeth.4324. Epub 2017 Jun 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验